Medical Properties Trust (MPW)
(Delayed Data from NYSE)
$4.51 USD
-0.12 (-2.59%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.51 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value F Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.51 USD
-0.12 (-2.59%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.51 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value F Growth A Momentum D VGM
Zacks News
Should iShares S&P MidCap 400 Value ETF (IJJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJJ
Should Vanguard S&P MidCap 400 ETF (IVOO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOO
Should Vanguard S&P MidCap 400 Value ETF (IVOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOV
Medical Properties (MPW) Q1 FFO Meet Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 0% and 0.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Should SPDR S&P 400 Mid Cap Value ETF (MDYV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MDYV
Medical Properties (MPW) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $20.19, moving +1.92% from the previous trading session.
Medical Properties (MPW) Stock Moves -0.39%: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $20.23, moving -0.39% from the previous trading session.
Medical Properties (MPW) Stock Moves -1.08%: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $21.14, moving -1.08% from the previous trading session.
Medical Properties (MPW) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $20.67, marking a +1.32% move from the previous day.
Medical Properties (MPW) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $20.21, marking a -1.41% move from the previous day.
Medical Properties (MPW) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $19.99, marking a -0.79% move from the previous day.
RTL or MPW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
RTL vs. MPW: Which Stock Is the Better Value Option?
Medical Properties (MPW) Tops Q4 FFO and Revenue Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 2.17% and 2.86%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Key Factors to Impact Medical Properties' (MPW) Q4 Earnings
by Zacks Equity Research
Improving fundamentals of its tenants and stellar revenues are likely to have aided Medical Properties' (MPW) Q4 performance.
What's in Store for Alexandria (ARE) This Earnings Season?
by Zacks Equity Research
Alexandria's (ARE) Q4 results are likely to reflect benefits of having premium properties in strategic cluster locations and creditworthy tenants.
Medical Properties (MPW) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed at $22.61 in the latest trading session, marking a -1.65% move from the prior day.
Medical Properties (MPW) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $22.99, moving +0.39% from the previous trading session.
Medical Properties (MPW) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $24.13, moving +1.64% from the previous trading session.
Medical Properties (MPW) Flat As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $23.51, marking no change from the previous day.
Medical Properties (MPW) Stock Moves -1.57%: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed at $23.21 in the latest trading session, marking a -1.57% move from the prior day.
Medical Properties (MPW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $23.45, marking a -0.76% move from the previous day.
Medical Properties (MPW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $22.66, moving -0.53% from the previous trading session.
Medical Properties (MPW) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $22.11, marking a +0.41% move from the previous day.
Medical Properties (MPW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $21.84, moving -0.46% from the previous trading session.
Medical Properties (MPW) Q3 FFO Match Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 0.00% and 1.19%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?